8-K | Jotup

SCYX STOCK ALERT: Robbins LLP Reminds Investors of the Upcoming Lead Plaintiff Deadline in the Class Action Against Scynexis, Inc.

Retrieved on:

Saturday, December 16, 2023

8-K, Fungal infection, Candidiasis, Risk, Biotechnology, LLP, FDA, GSK plc, Person, Complaint, CGMP, Incidence, SAN, News, Hypersensitivity, GSK, Allergy, Tablet, Good manufacturing practice, Patient

Scynexis is a biotechnology company that is primarily engaged in the development of ibrexafungerp, a broad-spectrum, intravenous (IV)/oral agent for fungal indications.

Key Points:

Scynexis is a biotechnology company that is primarily engaged in the development of ibrexafungerp, a broad-spectrum, intravenous (IV)/oral agent for fungal indications.
For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
What Now: Similarly situated shareholders may be eligible to participate in the class action against Scynexis, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

LIVEPERSON SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LivePerson To Contact Him Directly To Discuss Their Options

Retrieved on:

Friday, December 15, 2023

8-K, LivePerson, LLP, Acquisition, Court, Disclosure, News, Bank statement, LPSN, Medicare, Advertising, Annual report, Woman, Cryptocurrency

NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) and reminds investors of the January 30, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

If you suffered losses exceeding $50,000 investing in LivePerson stock or options between May 10, 2022 and March 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding LivePerson’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments in LivePerson, Inc. of Class Action Lawsuit and Upcoming Deadline – LPSN

Retrieved on:

Thursday, December 14, 2023

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points:

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

BRBS Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Blue Ridge Bankshares, Inc. Class Action

Retrieved on:

Wednesday, December 13, 2023

8-K, BRBS, Trust, LLP, Person, Complaint, Financial statement, SAN, News, Bank statement, BRB, Annual report, Cryptocurrency

Defendant Blue Ridge conducts its business activities through its “wholly-owned subsidiary bank, Blue Ridge Bank [.

Key Points:

Defendant Blue Ridge conducts its business activities through its “wholly-owned subsidiary bank, Blue Ridge Bank [.
On this news, the price of Blue Ridge stock fell $1.06 per share, or 33.65%, to close at $2.09 on November 1, 2023.
What Now: Similarly situated shareholders may be eligible to participate in the class action against Blue Ridge Bankshares, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of LivePerson, Inc. (LPSN) Investors and Encourages Investors to Contact the Firm Before January 30, 2024

Retrieved on:

Wednesday, December 13, 2023

8-K, District court, LivePerson, Acquisition, Court, News, Bank statement, LPSN, Medicare, Annual report, Pharmaceutical industry

Investors have until January 30, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points:

Investors have until January 30, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Then, on March 16, 2023, the Company filed the 2022 Annual Report with the U.S. Securities and Exchange Commission.
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Blue Ridge Bankshares, Inc. (BRBS)

Retrieved on:

Thursday, December 7, 2023

8-K, BRBS, Trust, LLP, Person, Complaint, Financial statement, SAN, News, Bank statement, BRB, Annual report, Cryptocurrency

SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Blue Ridge Bankshares, Inc. (NASDAQ: BRBS) securities between March 10, 2023 and October 31, 2023.

Key Points:

SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Blue Ridge Bankshares, Inc. (NASDAQ: BRBS) securities between March 10, 2023 and October 31, 2023.
Defendant Blue Ridge conducts its business activities through its “wholly-owned subsidiary bank, Blue Ridge Bank [.
On this news, the price of Blue Ridge stock fell $1.06 per share, or 33.65%, to close at $2.09 on November 1, 2023.
What Now: Similarly situated shareholders may be eligible to participate in the class action against Blue Ridge Bankshares, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

LIVEPERSON INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LivePerson To Contact Him Directly To Discuss Their Options

Retrieved on:

Thursday, December 7, 2023

8-K, LivePerson, LLP, Acquisition, Court, Disclosure, News, Bank statement, LPSN, Medicare, Advertising, Annual report, Woman, Cryptocurrency

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) and reminds investors of the January 30, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

If you suffered losses exceeding $50,000 investing in LivePerson stock or options between May 10, 2022 and March 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding LivePerson’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments in LivePerson, Inc. of Class Action Lawsuit and Upcoming Deadline – LPSN

Retrieved on:

Monday, December 4, 2023

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points:

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

LIVEPERSON SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LivePerson To Contact Him Directly To Discuss Their Options

Retrieved on:

Saturday, December 2, 2023

8-K, LivePerson, LLP, Acquisition, Court, Disclosure, News, Bank statement, LPSN, Medicare, Advertising, Annual report, Woman, Cryptocurrency

NEW YORK, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) and reminds investors of the January 30, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

If you suffered losses exceeding $50,000 investing in LivePerson stock or options between May 10, 2022 and March 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding LivePerson’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

First Busey Corporation and Merchants and Manufacturers Bank Corporation to Merge

Retrieved on:

Monday, November 27, 2023

Busey Bank, 8-K, Workforce, Partnership, LLP, Acquisition, Sumitomo Mitsui Banking Corporation, M&M, Merchant, Bank

CHAMPAIGN, Ill. and OAKBROOK TERRACE, Ill., Nov. 27, 2023 (GLOBE NEWSWIRE) -- First Busey Corporation (“Busey”) (NASDAQ:BUSE), the holding company for Busey Bank, and Merchants and Manufacturers Bank Corporation (”M&M”), the holding company for Merchants & Manufacturers Bank (“M&M Bank”), today jointly announced the signing of a definitive agreement pursuant to which Busey will acquire M&M Bank through a merger transaction.

Key Points:

CHAMPAIGN, Ill. and OAKBROOK TERRACE, Ill., Nov. 27, 2023 (GLOBE NEWSWIRE) -- First Busey Corporation (“Busey”) (NASDAQ:BUSE), the holding company for Busey Bank, and Merchants and Manufacturers Bank Corporation (”M&M”), the holding company for Merchants & Manufacturers Bank (“M&M Bank”), today jointly announced the signing of a definitive agreement pursuant to which Busey will acquire M&M Bank through a merger transaction.
It is anticipated M&M Bank will be merged with and into Busey Bank at a date following the completion of the merger.
At the time of the bank merger, M&M Bank banking centers will become branches of Busey Bank.
For additional information on First Busey Corporation’s planned acquisition of Merchants and Manufacturers Bank Corporation, please refer to the Investor Presentation furnished via Form 8-K on November 27, 2023, in connection with this press release.